Search Results - "Balslev, Eva"

PD-L1 expression in breast cancer: expression in subtypes and prognostic significance: a systematic review by Stovgaard, Elisabeth Specht, Dyhl-Polk, Anne, Roslind, Anne, Balslev, Eva, Nielsen, Dorte

“…Purpose To systematically review the literature on the expression of PD-L1 in primary BC, variation of expression between subtypes and effect on overall…”
Get full text

Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study by Groen, Emma J., Hudecek, Jan, Mulder, Lennart, van Seijen, Maartje, Almekinders, Mathilde M., Alexov, Stoyan, Kovács, Anikó, Ryska, Ales, Varga, Zsuzsanna, Andreu Navarro, Francisco-Javier, Bianchi, Simonetta, Vreuls, Willem, Balslev, Eva, Boot, Max V., Kulka, Janina, Chmielik, Ewa, Barbé, Ellis, de Rooij, Mathilda J., Vos, Winand, Farkas, Andrea, Leeuwis-Fedorovich, Natalja E., Regitnig, Peter, Westenend, Pieter J., Kooreman, Loes F. S., Quinn, Cecily, Floris, Giuseppe, Cserni, Gábor, van Diest, Paul J., Lips, Esther H., Schaapveld, Michael, Wesseling, Jelle

“…Purpose For optimal management of ductal carcinoma in situ (DCIS), reproducible histopathological assessment is essential to distinguish low-risk from…”
Get full text

Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase I gene by Kümler, Iben, Balslev, Eva, Stenvang, Jan, Brünner, Nils, Ejlertsen, Bent, Jakobsen, Erik Hugger, Nielsen, Dorte Lisbet

“…Treatment options in metastatic breast cancer are limited. New therapies preferable with predictive biomarkers are needed. The aim of these trials was to…”
Get full text

Retrospective Analysis of Topoisomerase IIa Amplifications and Deletions As Predictive Markers in Primary Breast Cancer Patients Randomly Assigned to Cyclophosphamide, Methotrexate, and Fluorouracil or Cyclophosphamide, Epirubicin, and Fluorouracil: Danish Breast Cancer Cooperative Group by KNOOP, Ann S, KNUDSEN, Helle, EJLERTSEN, Bent, BALSLEV, Eva, RASMUSSEN, Birgitte B, OVERGAARD, Jens, NIELSEN, Kirsten V, SCHONAU, Andreas, GUNNARSDOTTIR, Katrin, OLSEN, Karen E, MOUNDSEN, Henning

“…The aim of the study was to evaluate the predictive value of HER2 and topoisomerase IIalpha gene (TOP2A) for the efficacy of epirubicin in the adjuvant setting…”
Get full text

Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial by Bernsdorf, Mogens, Ingvar, Christian, Jörgensen, Leif, Tuxen, Malgorzata K, Jakobsen, Erik H, Saetersdal, Anna, Kimper-Karl, Marie Louise, Kroman, Niels, Balslev, Eva, Ejlertsen, Bent

“…Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, has shown both anti-proliferative and anti-tumoral activity in breast cancer. This…”
Get full text

The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine by Stovgaard, Elisabeth S, Asleh, Karama, Riaz, Nazia, Leung, Samuel, Gao, Dongxia, Nielsen, Lise B, Lænkholm, Anne-Vibeke, Balslev, Eva, Jensen, Maj-Britt, Nielsen, Dorte, Nielsen, TO

“…Preclinical studies suggest that some effects of conventional chemotherapy, and in particular, gemcitabine, are mediated through enhanced antitumor immune…”
Get full text

Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status by Rask, Lene, Balslev, Eva, Søkilde, Rolf, Høgdall, Estrid, Flyger, Henrik, Eriksen, Jens, Litman, Thomas

“…Purpose Therapeutic decisions in breast cancer are increasingly guided by prognostic and predictive biomarkers. Non-protein-coding microRNAs (miRNAs) have…”
Get full text

Evidence of No Association Between Human Papillomavirus and Breast Cancer by Bønløkke, Sara, Blaakær, Jan, Steiniche, Torben, Høgdall, Estrid, Jensen, Steffen Grann, Hammer, Anne, Balslev, Eva, Strube, Mikael Lenz, Knakkergaard, Helle, Lenz, Suzan

“…Globally, breast cancer is the most frequent cancer among women. Studies reported an increased risk of breast cancer among women with prior cervical dysplasia…”
Get full text

HER2, TOP2A, and TIMP-1 and Responsiveness to Adjuvant Anthracycline-Containing Chemotherapy in High-Risk Breast Cancer Patients by EJLERTSEN, Bent, JENSEN, Maj-Britt, NIELSEN, Kirsten V, BALSLEV, Eva, RASMUSSEN, Birgitte B, WILLEMOE, Gro L, HERTEL, Pernille B, KNOOP, Ann S, MOURIDSEN, Henning T, RÜNNER, Nils

“…PURPOSE To evaluate whether the combination of HER2 with TIMP-1 (HT) or TOP2A with TIMP-1 (2T) more accurately identifies patients who benefit from…”
Get full text

Iatrogenic displacement of tumor cells to the sentinel node after surgical excision in primary breast cancer by Tvedskov, Tove F., Jensen, Maj-Britt, Kroman, Niels, Balslev, Eva

“…Isolated tumor cells (ITC) are more common in the sentinel node (SN) after needle biopsy of a breast cancer, indicating iatrogenic displacement of tumor cells…”
Get full text

Prediction of fulvestrant efficacy in patients with advanced breast cancer: retrospective-prospective evaluation of the predictive potential of a multigene expression assay by Christensen, Troels Dreier, Buhl, Anna Sofie Kappel, Christensen, Ib Jarle, Buhl, Ida Kappel, Balslev, Eva, Knoop, Ann S., Danø, Hella, Glavicic, Vesna, Luczak, Adam, Langkjer, Sven Tyge, Linnet, Søren, Jakobsen, Erik Hugger, Bogovic, Jurij, Ejlertsen, Bent, Rasmussen, Annie, Hansen, Anker, Knudsen, Steen, Jensen, Peter Buhl, Nielsen, Dorte

“…Background Fulvestrant is a selective oestrogen receptor (ER) degrader used as monotherapy and combination therapy for ER positive HER2 negative advanced…”
Get full text

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group by Jørgensen, Charlotte Levin Tykjær, Bjerre, Christina, Ejlertsen, Bent, Bjerre, Karsten D, Balslev, Eva, Bartels, Annette, Brünner, Nils, Nielsen, Dorte L

“…Tissue inhibitor of metalloproteinases-1 (TIMP-1) has anti-apoptotic functions, which may protect TIMP-1 positive cancer cells from the effects of chemotherapy…”
Get full text

Identification and analysis of miRNAs in human breast cancer and teratoma samples using deep sequencing by Nygaard, Sanne, Jacobsen, Anders, Lindow, Morten, Eriksen, Jens, Balslev, Eva, Flyger, Henrik, Tolstrup, Niels, Møller, Søren, Krogh, Anders, Litman, Thomas

“…MiRNAs play important roles in cellular control and in various disease states such as cancers, where they may serve as markers or possibly even therapeutics…”
Get full text

Aberrations of ERBB2 and TOP2A genes in breast cancer by Nielsen, Kirsten Vang, Müller, Sven, Møller, Susanne, Schønau, Andreas, Balslev, Eva, Knoop, Ann S., Ejlertsen, Bent

“…Copy number changes in TOP2A have frequently been linked to ERBB2 ( HER2) amplified breast cancers. To study this relationship, copy number changes of ERBB2…”
Get full text

CD8 T-cell Responses against Cyclin B1 in Breast Cancer Patients with Tumors Overexpressing p53 by Sørensen, Rikke Baek, Andersen, Rikke Sick, Svane, Inge Marie, Engell-Noerregaard, Lotte, Hadrup, Sine R, Balslev, Eva, Andersen, Mads Hald, thor Straten, Per

“…Purpose: This study aimed to examine CD8 T-cell reactivity in breast cancer patients against cyclin B1–derived peptides restricted by the human leukocyte…”
Get full text

Amplification of HER2 and TOP2A and deletion of TOP2A genes in breast cancer investigated by new FISH probes by Olsen, Karen E, Knudsen, Helle, Rasmussen, Birgitte B, Balslev, Eva, Knoop, Ann, Ejlertsen, Bent, Nielsen, Kirsten V, Schönau, Andreas, Overgaard, Jens

“…New strategies for improving treatment of patients with breast carcinoma have focused on the HER2 oncoprotein with regard to response to traditional therapy…”
Get more information

Cytokeratin on Frozen Sections of Sentinel Node May Spare Breast Cancer Patients Secondary Axillary Surgery by Stovgaard, Elisabeth Specht, Tvedskov, Tove Filtenborg, Lænkholm, Anne Vibeke, Balslev, Eva

“…Background. The feasibility and accuracy of immunohistochemistry (IHC) on frozen sections, when assessing sentinel node (SN) status intraoperatively in breast…”
Get full text

Cystic soft tissue tumours of the dorsal aspect of the wrist have two distinct histological subtypes by Eriksen, Jamila, Balslev, Eva, Søe, Niels Henrik

“…In total, 38 patients with cystic dorsal wrist tumours managed with surgical excision were prospectively followed up for 2 years. Tissue was examined…”
Get full text

Comparison of Fluorescence In Situ Hybridization and Chromogenic In Situ Hybridization for Low and High Throughput HER2 Genetic Testing by Poulsen, Tim S., Espersen, Maiken L. M., Kofoed, Vibeke, Dabetic, Tanja, Høgdall, Estrid, Balslev, Eva

“…The purpose was to evaluate and compare 5 different HER2 genetic assays with different characteristics that could affect the performance to analyze the human…”
Get full text

Fibrolipomatous hamartoma in the median nerve in the arm - an unusual location but with MR imaging characteristics: a case report by Nilsson, Jessica, Sandberg, Kristina, Dahlin, Lars B, Vendel, Nina, Balslev, Eva, Larsen, Lone, Nielsen, Niels Søe

“…Fibrolipomatous hamartoma of the median nerve are usually located distally in the forearm and may have characteristic features on MR imaging. Here we report a…”
Get full text